SCHEMBL9587481

SCHEMBL9587481

Cc1ccccc1Cc1ccc(S(=O)(=O)c2ccc3ccccc3c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.47
LOXL2 Q9Y4K0 4/20 0.45
LOX P28300 2/20 0.45
MAOA P21397 1/20 0.45
LMNA P02545 1/20 0.44
PKM P14618 2/20 0.43
PKLR P30613 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KAT6A Q92794 1/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GAA P10253 1/20 0.42
CYP19A1 P11511 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7749413 0.87 MEN1 (0.47) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL9587487 0.85 L3MBTL1 (0.50) L3MBTL1LOXL2LOXMAOALMNA
SCHEMBL25381582 0.79 CYP2A6 (0.55) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL9589105 0.79 L3MBTL1 (0.54) L3MBTL1LOXL2LOXMAOALMNA
Bromide SCHEMBL9586294 0.78 L3MBTL1 (0.53) L3MBTL1LOXL2LOXMAOALMNA
SCHEMBL9587829 0.77 GAA (0.61) L3MBTL1LOXL2LOXMAOALMNA
SCHEMBL28245578 0.77 GAA (0.51) L3MBTL1LMNAPKMPKLRMEN1
SCHEMBL1952494 0.77 LMNA (0.68) L3MBTL1LOXL2LOXMAOALMNA
SCHEMBL9586629 0.76 LOXL2 (0.50) L3MBTL1LOXL2LOXMAOALMNA
SCHEMBL9587491 0.76 HTR6 (0.54) L3MBTL1LOXL2LOXMAOALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993013079-A1 ANTIFOLATE QUINAZOLINES AGOURON PHARMACEUTICALS, INC. (US) 1993-07-08 WO disclosed